Moderna, Inc. has announced promising early results from its investigational cancer therapy, mRNA-4359. This data will be presented at the 2025 European Society for Medical Oncology...
Moderna has announced promising results for its updated COVID-19 vaccine, targeting the LP.8.1 variant. Preliminary analysis indicates that the 2025-2026 formula of Spikevax has generated a...
Companies producing COVID-19 vaccines, including Pfizer and Moderna, have announced plans to conduct new clinical trials aimed at evaluating their vaccines in younger populations. This commitment...
Companies that manufacture COVID-19 vaccines, including Pfizer and BioNTech, have announced their commitment to conduct new trials aimed at assessing the safety and efficacy of their...
The U.S. Food and Drug Administration (FDA) has approved updated versions of the COVID-19 vaccines from Pfizer and Moderna, but has limited eligibility to high-risk groups....
